Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Ironwood Pharmaceuticals (IRWD) over the last 11 years, with Dec 2024 value amounting to $0.01.

  • Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) rose 1050.00% to $0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.15, marking a year-over-year increase of 600.00%. This contributed to the annual value of $0.01 for FY2024, which is 100.16% up from last year.
  • Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to $0.01 in FY2024, which was up 100.16% from -$6.45 recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $3.21 in FY2021 and a low of -$6.45 during FY2023.
  • For the 3-year period, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$1.83, with its median value being $0.01 (2024).
  • In the last 5 years, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) spiked by 386.36% in 2021 and then crashed by 771.88% in 2023.
  • Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at $0.66 in 2020, then soared by 386.36% to $3.21 in 2021, then plummeted by 70.09% to $0.96 in 2022, then plummeted by 771.88% to -$6.45 in 2023, then surged by 100.16% to $0.01 in 2024.